CMINDS

Computerized Multiphasic Interactive Neurocognitive DualDisplay System


The Computerized Multiphasic Interactive Neurocognitive DualDisplayTM System (CMINDS®) is a next-generation neurocognitive and behavioral assessment system that is uniquely defined by a DualDisplayTM architecture that integrates rather than replaces an Examiner in the process of evaluation. This architecture affords advanced capabilities especially relevant for assessment of people who require ongoing assistance to understand and complete testing.

CMINDS® hosts over 30 fully computerized neurocognitive tests, the widest range available. Accordingly, CMINDS® is applicable across a wide spectrum of central nervous system disorders, including:

  1. Alzheimer's Disease,
  2. Schizophrenia,
  3. Traumatic Brain Injury (TBI),
  4. Neurotoxicological insult,
  5. Stroke,
  6. HIV encephalopathy and
  7. other acquired brain disorders.

CMINDS® provides a multimedia-capable platform that features digitally recorded human-voice instructions, detailed report generation, integrated data management utilities and integrated examiner training modules for certification-contingent access control.

CMINDS® is fully compatible with and shares a common database with ClintabTM, a mobile, tablet PC-based, data capture system which hosts key behavioral and psychiatric measures for clinical trials. This allows all assessment data collected for clinical trials to be integrated immediately.

CMINDS® has been utilized in Phase I, II & III clinical trails, as well as investigator-initiated studies, at over 100 leading institutions throughout the U.S., Canada and South America over the past 8 years.

The development of CMINDS® was funded by the National Institute of Mental Health (NIMH)* and the National Institute on Aging (NIA)** to provide efficient computerized versions of commonly applied, established tests, as opposed to unique or proprietary designs.